NEW YORK (GenomeWeb) – Waters announced that it has extended a partnership with Singapore's Agency for Science, Technology, and Research (A*Star) to develop new mass spectrometry –based techniques for finding glycan-related biomarkers.

Under the terms of the agreement, Waters will work with A*Star's Bioprocessing Technology Institute to develop a database of glycosphingolipid (GSL) head groups, containing glucose unit retention times and cross-section values. The partners will also compile a comprehensive glycan spectral library for cancer glycobioloy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Sponsored by

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.

Sponsored by

About one year ago, the Association for Molecular Pathology (AMP), with liaison representation from the American College of Medical Genetics and Genomics (ACMG), American Society of Clinical Oncology (ASCO), and College of American Pathologists (CAP), released a guideline on reporting somatic cancer variants.